H.R. 3537House114th Congress (2015-2017)Passed House

Dangerous Synthetic Drug Control Act of 2016

Legislative Activity

Stay on top of the latest movement without scrolling through every action

23 earlier actions

SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Judiciary Committee

September 27, 2016

View full timeline

HouseIntro Referral

Introduced in House

September 17, 2015

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

September 17, 2015

HouseCommittee

Referred to the Subcommittee on Health.

Health Subcommittee

September 18, 2015

HouseCommittee

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Crime and Federal Government Surveillance Subcommittee

October 5, 2015

HouseCommittee

Subcommittee Consideration and Mark-up Session Held.

Health Subcommittee

November 3, 2015

HouseCommittee

Subcommittee Consideration and Mark-up Session Held.

Health Subcommittee

November 4, 2015

HouseCommittee

Forwarded by Subcommittee to Full Committee by Voice Vote .

Health Subcommittee

November 4, 2015

HouseCommittee

Committee Consideration and Mark-up Session Held.

Energy and Commerce Committee

November 17, 2015

HouseCommittee

Committee Consideration and Mark-up Session Held.

Energy and Commerce Committee

September 20, 2016

HouseCommittee

Committee Consideration and Mark-up Session Held.

Energy and Commerce Committee

September 21, 2016

HouseCommittee

Ordered to be Reported (Amended) by Voice Vote.

Energy and Commerce Committee

September 21, 2016

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-787, Part I.

Energy and Commerce Committee

September 26, 2016

HouseCommittee

Committee on the Judiciary discharged.

Judiciary Committee

September 26, 2016

HouseCalendars

Placed on the Union Calendar, Calendar No. 615.

September 26, 2016

HouseFloor

Mr. Guthrie moved to suspend the rules and pass the bill, as amended.

September 26, 2016 • 2:18 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H5871-5874)

September 26, 2016 • 2:18 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 3537.

September 26, 2016 • 2:18 PM

HouseFloor

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

September 26, 2016 • 2:31 PM

HouseFloor

Considered as unfinished business. (consideration: CR H5893)

September 26, 2016 • 6:32 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 258 - 101 (Roll no. 557).(text: CR H5871-5872)

View vote Passed

September 26, 2016 • 6:52 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 258 - 101 (Roll no. 557). (text: CR H5871-5872)

View vote Passed

September 26, 2016 • 6:52 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

September 26, 2016 • 6:52 PM

HouseFloor

The title of the measure was amended. Agreed to without objection.

September 26, 2016 • 6:52 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Judiciary Committee

September 27, 2016

Voting History

1 vote recorded • Roll call available

HOUSE

Roll Call Available

September 26, 2016 at 6:52 PM

On Motion to Suspend the Rules and Pass, as Amended

Majority required: 2/3 (66.7%)

Passed

258 - 101

Bill Text

4 versions available

Reading Mode

Raw Text PDF XML

Referred in SenateIssued September 27, 2016

IIB

114th CONGRESS

2d Session

H. R. 3537

IN THE SENATE OF THE UNITED STATES

September 27, 2016

Received; read twice and referred to the Committee on the Judiciary

AN ACT

To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes.

Short title

This Act may be cited as the Dangerous Synthetic Drug Control Act of 2016.

Treatment of certain designer drugs as schedule I controlled substances

(a)

Cannabimimetic agents

Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (d)(2)(B)—

(1)

in clause (xiv) by striking and at the end;

(2)

in clause (xv) by striking the period and inserting a semicolon; and

(3)

by adding at the end the following:

(xvi)

2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–251);

(xvii)

(1-butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone (4′-methyl JWH–073);

(xviii)

2-(3-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone (JWH–302);

(xix)

N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5F–APICA);

(xx)

quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F–PB–22);

(xxi)

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB–PINACA);

(xxii)

N-(naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide (MN–24);

(xxiii)

(1-(5-fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ–2201);

(xxiv)

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADBICA);

(xxv)

methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F–AMB); and

(xxvi)

methyl 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (MA–CHMINACA).

(b)

Synthetic opioids

Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (a) by adding at the end the following:

(43)

Butyryl fentanyl.

(44)

beta-Hydroxythiofentanyl.

(45)

Acetyl fentanyl.

(c)

Other drugs

Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended in subsection (c) by adding at the end the following:

(29)

1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-naphyrone).

(30)

1-(2,3-dihydrobenzofuran-5-yl)propan-2-amine (5–APDB).

(31)

1-(2,3-dihydrobenzofuran-6-yl)propan-2-amine (6–APDB).

(32)

6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine (MDAI).

(33)

5-iodo-2,3-dihydro-1H-inden-2-amine (5–IAI).

(34)

1-(4-bromofuro[2,3-f]benzofuran-8-yl)propan-2-amine (bromo-dragonfly).

(35)

1-(4-chloro-2,5-dimethoxyphenyl)propan-2-amine (DOC).

(36)

1-(4-ethoxy-2,5-dimethoxyphenyl)propan-2-amine (MEM).

Passed the House of Representatives September 26, 2016.

Karen L. Haas,

Clerk.